Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model

Instead of relying on external anticancer factors for treatment, immunotherapy utilizes the hosts own immune system and directs it against given tumour antigens. This study demonstrated that it is possible to overcome the documented immunosuppressive properties of tumour cell lysate by supplementing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology reports 2017-01, Vol.37 (1), p.171-178
Hauptverfasser: Kraśko, Jan Aleksander, Žilionytė, Karolina, Darinskas, Adas, Strioga, Marius, Rjabceva, Svetlana, Zalutsky, Iosif, Derevyanko, Marina, Kulchitsky, Vladimir, Lubitz, Werner, Kudela, Pavol, Miseikyte-Kaubriene, Edita, Karaman, Olha, Didenko, Hennadii, Potebnya, Hryhorii, Chekhun, Vasyl, Pašukonienė, Vita
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Instead of relying on external anticancer factors for treatment, immunotherapy utilizes the hosts own immune system and directs it against given tumour antigens. This study demonstrated that it is possible to overcome the documented immunosuppressive properties of tumour cell lysate by supplementing it with appropriate adjuvant. Lewis lung carcinoma (LLC)-challenged C57BL/6 mice were treated with LLC cryo-lysate mixed with either bacterial ghosts (BGs) generated from E. coli Nissle 1917 or B. subtilis 70 kDa protein as adjuvants. Median and overall survival, the size of metastatic foci in lung tissue and levels of circulating CD8a+ T cells were evaluated and compared to the untreated control mice or mice treated with LLC lysate alone. After primary tumour removal, a course of three subcutaneous vaccinations with LLC lysate supplemented with BGs led to a significant increase in overall survival (80% after 84 days of follow-up vs. 40% in untreated control mice), a significant increase in circulating CD8a+ T cells (16.57 vs. 12.6% in untreated control mice) and a significant decrease in metastasis foci area and incidence. LLC lysate supplemented with B. subtilis protein also improved the inspected parameters in the treated mice, when compared against the untreated control mice, but not to a significant degree. Therefore, whole cell lysate supplemented with BGs emerges as an immunostimulatory construct with potential clinical applications in cancer treatment.
ISSN:1021-335X
1791-2431
DOI:10.3892/or.2016.5252